A comprehensive review of tricuspid regurgitation highlights the clinical significance of moderate-to-severe disease and discusses evolving management strategies, including percutaneous therapies.
This review highlights the importance of actively managing moderate to severe tricuspid regurgitation, challenging the traditional belief that functional TR resolves spontaneously when underlying disease is treated.
Tricuspid regurgitation (TR) is the most common lesion of the tricuspid valve (TV). Mild TR is common and usually is benign. However, moderate or severe TR can lead to irreversible myocardial damage and adverse outcomes. Despite these findings, few patients with significant TR undergo surgery. The treatment of functional (secondary) TR in particular remains controversial because of high rates of residual or recurrent TR and poor outcomes following surgical intervention. Traditional teaching that functional TR resolves on its own if the underlying disease is successfully treated has proven to be incorrect. This review aims to clarify management of TR by describing the anatomy, pathophysiology, diagnosis, and treatment of TR, including the eventual possibility of percutaneous TV therapy.
Arsalan et al. (Thu,) conducted a review in Tricuspid regurgitation. Diagnosis and treatment strategies was evaluated. A comprehensive review of tricuspid regurgitation highlights the clinical significance of moderate-to-severe disease and discusses evolving management strategies, including percutaneous therapies.